tiprankstipranks
Trending News
More News >
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (DE:6NQ)
FRANKFURT:6NQ
Advertisement

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (6NQ) Revenue

Compare
0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Revenue

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. had a revenue of 13.43M in the quarter ending Mar 31, 2025, with -54.09%. This bring the company's revenue in the last twelve months to 71.28M, Increased -0.66%. In the fiscal year ending Dec 31, 2024, Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. had annual revenue of 71.76M with 22.44% growth.
Revenue (ttm)
71.28M
Revenue Growth
P/S Ratio
0.99
Revenue/Employee
€300,234
Employees
239
Market Cap
€71.27M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
71.76M13.15M+122.44%
Dec 31, 2023
58.61M8.22M+116.32%
Dec 31, 2022
50.38M9.23M+122.43%
Dec 31, 2021
41.15M995.00K+102.48%
Dec 31, 2020
40.16M1.05M+102.69%
Dec 31, 2019
39.11M6.81M+121.10%
Dec 31, 2018
32.29M889.00K+102.83%
Dec 31, 2017
31.40M-4.93M+86.42%
Dec 31, 2016
36.34M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis